Orenitram and Unituxin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Orenitram (treprostinil) and Unituxin (dinutuximab). Common drug interactions include weight decreased among females and cardiac disorder among males.

The phase IV clinical study analyzes what interactions people have when they take Orenitram and Unituxin. It is created by eHealthMe based on reports of 23 people who take the same drugs from the FDA, and is updated regularly.

What is Orenitram?

Orenitram has active ingredients of treprostinil. eHealthMe is studying from 17,714 Orenitram users. Check the latest studies of Orenitram.

What is Unituxin?

Unituxin has active ingredients of dinutuximab. eHealthMe is studying from 489 Unituxin users. Check the latest studies of Unituxin.



On Apr, 19, 2026

23 people who take Orenitram and Unituxin together, and have interactions are studied.

Orenitram and Unituxin drug interactions.

What are the common drug interactions of Orenitram and Unituxin, by gender? *:

female:

  1. Weight decreased
  2. Death
  3. Nausea (feeling of having an urge to vomit)
  4. Vomiting
  5. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  6. Decreased appetite
  7. Gastrointestinal disorder (functional problems of gastrointestinal tract)
  8. Malaise (a feeling of general discomfort or uneasiness)
  9. Presyncope
  10. Chest pain

male:

  1. Cardiac disorder
  2. Death
  3. Cardiac murmur (an heart sound in valve abnormality)
  4. Fluid retention (an abnormal accumulation of fluid in the blood)
  5. Heart rate increased
  6. Obstructive airways disorder (a progressive disease that makes it hard to breathe)
  7. Pulmonary hypertension (increase in blood pressure in the lung artery)
  8. Weight decreased

What are the common drug interactions of Orenitram and Unituxin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Dyspnoea (difficult or laboured respiration)
  2. Hypoaesthesia (reduced sense of touch or sensation)
  3. Migraine (headache)

30-39:

n/a

40-49:

n/a

50-59:

  1. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  2. Decreased appetite
  3. Headache (pain in head)
  4. Malaise (a feeling of general discomfort or uneasiness)
  5. Weight decreased
  6. Heart rate increased
  7. Acute respiratory failure
  8. Death
  9. Paralysis

60+:

  1. Headache (pain in head)
  2. Neck pain
  3. Nasal congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels)
  4. Nausea (feeling of having an urge to vomit)
  5. Rash
  6. Rhinalgia (pain in the nose)
  7. Spinal pain (pain in spine)
  8. Wound
  9. Pain
  10. Rhinorrhoea (watery mucus discharge from the nose)

What are the existing conditions these people have? *

  1. Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 8 people, 34.78%

* Approximation only. Some reports may have incomplete information.

Do you take Orenitram and Unituxin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Orenitram and Unituxin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Orenitram:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Unituxin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Orenitram and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Unituxin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on treprostinil and dinutuximab (the active ingredients of Orenitram and Unituxin, respectively), and Orenitram and Unituxin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: